A Bivalent Omicron-Containing Booster Vaccine against Covid-19Spyros Chalkias, Rituparna Das, Andrea Sutherland et al.|New England Journal of Medicine|2022Cited by 649
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trialSpyros Chalkias, Rituparna Das, Frank Eder et al.|Nature Medicine|2022Cited by 144
A Bivalent Omicron-containing Booster Vaccine Against Covid-19Spyros Chalkias, Rituparna Das, Charles Harper et al.|medRxiv|2022Cited by 76
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19Spyros Chalkias, Rituparna Das, Charles Harper et al.|Nature Communications|2023Cited by 28
Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster VaccineSpyros Chalkias, Rituparna Das, Frank Eder et al.|Research Square|2022Cited by 24